Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ukr Biokhim Zh (1999) ; 85(2): 45-51, 2013.
Artigo em Ucraniano | MEDLINE | ID: mdl-23808309

RESUMO

With the introduction of doxorubicin into mice with Lewis carcinoma in the heart and liver tissues and kidney the organ-antitoxic effects of N-stearoilethanolamine (NSE) were found, which depended on its concentration. Administration of doxorubicin to male mice leads to an increase in the level of urea and creatinine, as well as activation of ALT in blood plasma. Introduction of NSE resulted in normalization of these parameters to the level of intact animals. In the heart tissue doxorubicin has multidirectional effects on the activity of antioxidant enzymes, in particular it decreases the activity of catalase and superoxide dismutase activity increases. Introduction of NSE normalizes these two indicators. It was found that tumor growth leads to an increase in the activity of glutathione peroxidase and superoxide dismutase. Introduction of NSE normalizes activity of these enzymes. Doxorubicin causes an increase in catalase activity in the kidney of mice with tumour, NSE prevented the increase in the activity of the above enzyme. The cancer process leads to increased levels of catalase activity in the liver of tumour-bearing mice, the introduction of NSE decreases the enzyme activity.


Assuntos
Antioxidantes/uso terapêutico , Carcinoma Pulmonar de Lewis/tratamento farmacológico , Doxorrubicina/toxicidade , Etanolaminas/uso terapêutico , Rim/efeitos dos fármacos , Fígado/efeitos dos fármacos , Miocárdio/enzimologia , Ácidos Esteáricos/uso terapêutico , Alanina Transaminase/sangue , Alanina Transaminase/metabolismo , Animais , Antioxidantes/administração & dosagem , Antioxidantes/metabolismo , Aspartato Aminotransferases/sangue , Aspartato Aminotransferases/metabolismo , Nitrogênio da Ureia Sanguínea , Carcinoma Pulmonar de Lewis/sangue , Carcinoma Pulmonar de Lewis/enzimologia , Creatinina/sangue , Relação Dose-Resposta a Droga , Doxorrubicina/uso terapêutico , Etanolaminas/administração & dosagem , Rim/enzimologia , Rim/metabolismo , Fígado/enzimologia , Masculino , Camundongos , Miocárdio/metabolismo , Especificidade de Órgãos , Ácidos Esteáricos/administração & dosagem
2.
Ukr Biokhim Zh (1999) ; 85(5): 97-104, 2013.
Artigo em Ucraniano | MEDLINE | ID: mdl-24479327

RESUMO

The aim of the study was to evaluate the possibility to reduce the doxorubicin toxic effects by its immobilization with N-stearoylethanolamine (NSE) on nanocarier polyethylene glycol. The studied parameters of the doxorubicin toxicity were: the level of creatinine in the mice blood plasma and activity of alanine aminotransferase and aspartate aminotransferase in the blood plasma of mice. The activity of catalase superoxide dismutase, glutathione peroxidase and intensity of lipid peroxidation was determined in the tissues of the heart, kidneys and liver. Doxorubicin in the content of nanocarrier alone caused an increase of serum creatinine and aspartateaminotrasferase activity in plasma of experimental animals with carcinoma. Nanocomposite which contained doxorubicin and NSE, did not cause an increase of these parameters. It has been shown that the administration of a carrier containing doxorubicin to mice with Lewis lung carcinoma caused the decrease of catalase activity in mice with carcinoma. The combination of NSE and doxorubicin on the carrier led to the normalization of this parameter to the level of intact animals. NSE immobilized on a carrier together with doxorubicin caused a decrease in the activity of superoxide dismutase in the kidney tissue of mice with tumor. The tumor growth caused the increase of the of superoxide dismutase in mice. The administration of a carrier which contained doxorubicin and NSE normalized superoxide dismutase in heart tissue contrary of kidney. The obtained results show the antitoxic and antioxidant effects of N-stearoylethanolamine immobilized in the nanocarrier complex together with doxorubicin.


Assuntos
Antibióticos Antineoplásicos/farmacologia , Antioxidantes/farmacologia , Carcinoma Pulmonar de Lewis/tratamento farmacológico , Doxorrubicina/farmacologia , Etanolaminas/farmacologia , Ácidos Esteáricos/farmacologia , Alanina Transaminase/sangue , Animais , Antibióticos Antineoplásicos/química , Antioxidantes/química , Aspartato Aminotransferases/sangue , Carcinoma Pulmonar de Lewis/metabolismo , Catalase/antagonistas & inibidores , Catalase/metabolismo , Creatinina/sangue , Doxorrubicina/química , Etanolaminas/química , Glutationa Peroxidase/metabolismo , Coração/efeitos dos fármacos , Rim/efeitos dos fármacos , Rim/metabolismo , Peroxidação de Lipídeos/efeitos dos fármacos , Fígado/efeitos dos fármacos , Fígado/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Nanocompostos , Polietilenoglicóis/química , Ácidos Esteáricos/química , Superóxido Dismutase/antagonistas & inibidores , Superóxido Dismutase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...